Akimitsu Makino

Title: Akimitsu Makino: Innovator in Ophthalmic Formulations

Introduction

Akimitsu Makino is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of ophthalmology through his innovative patent. His work focuses on the treatment and prevention of eyelid swelling, showcasing his dedication to improving patient care.

Latest Patents

Akimitsu Makino holds a patent for a "Method for the treatment and prevention of eyelid swelling." This invention features novel topical ophthalmic formulations that comprise an osmotically active agent and a vasoconstrictor. Suitable osmotically active agents include sodium chloride, dextrose, glycerine, sucrose, mannitol, and sorbitol. The vasoconstrictors used in these formulations include naphazoline and oxymetazoline. The patent outlines methods for using these formulations to treat and prevent eyelid swelling by administering them to the eye surface of a subject in need.

Career Highlights

Akimitsu Makino is associated with Aciex Therapeutics, Inc., where he continues to develop innovative solutions in ophthalmology. His work has the potential to significantly impact the treatment of eyelid conditions, enhancing the quality of life for many patients.

Collaborations

Some of his notable coworkers include Matthew Jonathan Chapin and Mark Barry Abelson. Their collaboration contributes to the advancement of research and development in the field.

Conclusion

Akimitsu Makino's contributions to ophthalmic formulations demonstrate his commitment to innovation in healthcare. His patent for treating eyelid swelling is a testament to his expertise and dedication to improving patient outcomes.